📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

KL*VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE*4 carriers. (2021)

First Author: Belloy ME
Attributed to:  MICA: Medical Bioinformatics: Data-Driven Discovery for Personalised Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.neurobiolaging.2021.01.008

PubMed Identifier: 33610961

Publication URI: http://europepmc.org/abstract/MED/33610961

Type: Journal Article/Review

Volume: 101

Parent Publication: Neurobiology of aging

ISSN: 0197-4580